These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22491275)

  • 1. The art of the alliance.
    Menzel GE; Xanthopoulos KG
    Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275
    [No Abstract]   [Full Text] [Related]  

  • 2. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 3. Public-private partnerships need honest brokering.
    Goldman M
    Nat Med; 2012 Mar; 18(3):341. PubMed ID: 22395691
    [No Abstract]   [Full Text] [Related]  

  • 4. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging public private partnerships to innovate under challenging budget times.
    Portilla LM; Rohrbaugh ML
    Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 8. The calculus of cures.
    Kocher R; Roberts B
    N Engl J Med; 2014 Apr; 370(16):1473-5. PubMed ID: 24571723
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 10. Europe bets on drug discovery.
    Baker M
    Nature; 2013 Feb; 494(7435):20. PubMed ID: 23393658
    [No Abstract]   [Full Text] [Related]  

  • 11. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 12. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.
    Ingrosso L; Rezza G; Pocchiari M; Garaci E
    Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551
    [No Abstract]   [Full Text] [Related]  

  • 13. Partners in discovery.
    Fuyuno I
    Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400
    [No Abstract]   [Full Text] [Related]  

  • 14. We Can use Market Forces to Moderate Drug Prices.
    Miller HI
    Mo Med; 2019; 116(6):451-453. PubMed ID: 31911716
    [No Abstract]   [Full Text] [Related]  

  • 15. Universities shun Europe's drug initiative.
    Gilbert N
    Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770
    [No Abstract]   [Full Text] [Related]  

  • 16. Making translation work.
    Williams RS; Desmond-Hellmann S
    Science; 2011 Jun; 332(6036):1359. PubMed ID: 21680815
    [No Abstract]   [Full Text] [Related]  

  • 17. The $2.6 billion pill--methodologic and policy considerations.
    Avorn J
    N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049
    [No Abstract]   [Full Text] [Related]  

  • 18. How can we improve the translational landscape for a faster cure of type 1 diabetes?
    von Herrath M; Chan A
    J Clin Invest; 2009 May; 119(5):1061-5. PubMed ID: 19422092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to help the free market fight coronavirus.
    Burley SK
    Nature; 2020 Apr; 580(7802):167. PubMed ID: 32210376
    [No Abstract]   [Full Text] [Related]  

  • 20. The innovative medicines initiative: a case study for new ways of working in drug R&D.
    Laverty H; Goldman M
    Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.